系统综述与Meta分析评估八旬老人因复杂主动脉瘤行开窗或分支腔内主动脉修复术的安全性与早期死亡率
该系统综述与Meta分析评估八旬老人因胸腹主动脉瘤(TAAA)行开窗或分支腔内主动脉修复术(F/BEVAR)的30天死亡率及其他结局。共纳入9项研究,汇总分析显示八旬老人与非八旬老人的30天死亡率无统计学差异(OR 1.73,95%CI 1.13-2.63,P=0.250);IV型TAAA亚组分析亦无统计学差异(OR 1.89,95%CI 0.75-4.77,P=0.163)。脊髓缺血、肾损伤、短暂性脑缺血发作或卒中、非家庭出院及全因再干预等结局在老年人群中均无统计学差异。
要点
- 八旬老人因TAAA行F/BEVAR的30天死亡率与非八旬老人相比无统计学差异(OR 1.73,95%CI 1.13-2.63,P=0.250)。
- IV型TAAA亚组中八旬老人与非八旬老人的30天死亡率无统计学差异(OR 1.89,95%CI 0.75-4.77,P=0.163)。
- 脊髓缺血、肾损伤、短暂性脑缺血发作或卒中、非家庭出院及全因再干预在老年人群中均无统计学差异。
核心结论
- 八旬老人与非八旬老人因TAAA行F/BEVAR的30天死亡风险无统计学差异,该结果在IV型TAAA亚组Meta分析及其他结局中一致。
研究设计与样本
- 系统综述与Meta分析,方案注册于国际前瞻性系统综述注册数据库(CRD42023435673),检索PubMed和Scopus自建库至2024年5月,遵循PRISMA指南,仅纳入报告F/BEVAR后30天死亡率的研究,采用非随机干预研究偏倚风险评估工具(ROBINS-I)评价偏倚风险。
- 共纳入9项研究符合Meta分析标准,其中7项研究中3项专门报告IV型TAAA的F/BEVAR。
主要发现
- 基于随机效应模型,八旬老人因任何类型TAAA行F/BEVAR的30天死亡率高于非八旬老人(OR 1.73,95%CI 1.13-2.63,P=0.250),但无统计学差异。
- IV型TAAA的Meta分析同样显示八旬老人与非八旬老人30天死亡率无统计学差异(OR 1.89,95%CI 0.75-4.77,P=0.163)。
- 脊髓缺血、肾损伤、短暂性脑缺血发作或卒中、非家庭出院及全因再干预等结局在老年人群中均无统计学差异。
关键数值与推荐
- 八旬老人因任何类型TAAA行F/BEVAR的30天死亡率汇总OR为1.73(95%CI 1.13-2.63,P=0.250)。
- IV型TAAA亚组八旬老人行F/BEVAR的30天死亡率汇总OR为1.89(95%CI 0.75-4.77,P=0.163)。
临床怎么用
- 对老年患者行F/BEVAR时,应权衡患者健康相关因素及系统因素(如外科医生技术和术后护理)。
- 作者认为需要进一步研究以评估和更好地理解合并症对手术结局的影响。
局限性
- 作者指出需要进一步研究以评估和更好地理解合并症对手术结局的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The population in the United States and across the world is aging rapidly which warrants an assessment of the safety of surgical approaches in elderly individuals to better risk stratify and inform surgeons' decision-making for optimal patient care. This review is designed to assess the risk of 30-day mortality and other outcomes of interest among the octogenarians undergoing fenestrated or branched endovascular aortic aneurysm repair (F/BEVAR) for thoracoabdominal aortic aneurysms (TAAAs). METHODS: The review protocol was registered in the international prospective register of systematic reviews database (CRD42023435673). A systematic review of the English literature was performed using literature databases PubMed and Scopus from inception till May 2024. The review was designed on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and included only studies reporting 30-day mortality following F/BEVAR. The risk of bias was evaluated using the Risk of Bias in Nonrandomized Studies of Interventions tool. A pooled odds ratio (OR) for the overall mortality was computed, and a P value of < 0.05 was designated as statistically significant. Interstudy heterogeneity was evaluated by Q-metric and quantified using Higgins I2 statistics. RESULTS: Nine studies were found fit for the meta-analysis per inclusion and exclusion criteria. Of these 7 studies, 3 exclusively reported F/BEVAR for Type IV TAAA. Based on a random-effects model, a 30-day mortality for octogenarians undergoing F/BEVAR for any type of TAAA was found to be higher (OR, 1.73; 95% confidence interval, 1.13-2.63, P = 0.250), however was not statistically different as compared to nonoctogenarians. This insignificance was pertinent, when a meta-analysis with similar model was computed for Type IV TAAA (OR, 1.89; 95% confidence interval, 0.75-4.77, P = 0.163). Other outcomes including spinal cord ischemia, kidney injury, transient ischemic attack or stroke, nonhome discharge, and all-cause reintervention were all found not to be statistically significant in the older population. CONCLUSION: No statistical difference was observed for the risk of 30-day mortality in octogenarians versus nonoctogenarians undergoing F/BEVAR for TAAA. This finding was consistent in subgroup meta-analysis of F/BEVAR for Type IV TAAAs and all other outcomes. Factors pertaining to patient's health and the system factors like surgeon's skills and postoperative care should be weighed when performing F/BEVAR in older patients. Further research is imperative to assess and better understand the impact of comorbidities on surgical outcomes.
引用
- Zil-E-Ali A, Paracha AW, Alamarie B, et al. Systematic Review and Meta-Analysis to Assess Safety and Early Mortality in Octogenarians Undergoing Fenestrated and Branched Endovascular Aortic Repair for Complex Aortic Aneurysms. Ann Vasc Surg. 2025. PMID: 39863275. doi:10.1016/j.avsg.2024.12.082
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。